As shown in Figure 4C, the expression of CDKN1A and CDKN1B was scarce in untreated MDS-L cells, but after DAC treatment, the expression of CDKN1A and CDKN1B was upregulated with drug maintenance application. The gene discussed is CDKN1A; the disease is myelodysplastic syndrome.